Why Eurofins Scientific (ENXTPA:ERF) is back on investor radars Eurofins Scientific (ENXTPA:ERF) has drawn fresh attention after cancelling 6,163,000 previously repurchased shares, trimming its share ...

Eurofins Scientific SE (the "Company" or "Eurofins") (EUFI.PA) (Paris:ERF) announces that its Board of Directors has decided on the cancellation of 6,163,000 shares, representing 3.38% of the ...

Eurofins Lancaster Laboratories plans to break ground this spring on a $147 million expansion that will add biopharmaceutical testing labs and office space.

Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached i (including the issuer ID allocated by the CSSF) EUROFINS SCIENTIFIC SE ...

Eurofins Scientific (EUFI) has delivered a 41.95% change over the past year, with a 52-week range between 46.00 and 74.32. What Is the Average Daily Trading Volume of Eurofins Scientific (EUFI)? The ...

EUROFINS SCIENT (ERFSF) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

Eurofins Supplement Testing and the Eurofins Assurance network are pleased to announce that their Certified Dietary Supplement and Clean Sport Certified programs are now incorporated into SuppCo’s ...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Eurofins Scientific (EUFI.PA), a European leader in Forensic DNA and Toxicology testing in France, Germany and Belgium, announces ...

Eurofins Lancaster Laboratories on Monday announced that it will add a new 300,000-square-foot biopharmaceutical testing facility and office to its Leola campus, costing about $147 million and adding ...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific (EUFI.PA) (Paris:ERF), a global scientific leader in bioanalytical testing, announces the successful closing of the transaction to ...